Issue navigation
Volume 78, Issue 5, May 2023
Reviews
Gepotidacin: a novel, oral, ‘first-in-class’ triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1137–1142, https://doi.org/10.1093/jac/dkad060
Nirsevimab: review of pharmacology, antiviral activity and emerging clinical experience for respiratory syncytial virus infection in infants
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1143–1149, https://doi.org/10.1093/jac/dkad076
Systematic Review
Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1150–1159, https://doi.org/10.1093/jac/dkad078
Original Research
Resistance is common in paediatric patients failing ART in South Africa
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1160–1167, https://doi.org/10.1093/jac/dkac443
Genomic comparison of mecC-carrying methicillin-resistant Staphylococcus aureus from hedgehogs and humans in the Netherlands
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1168–1174, https://doi.org/10.1093/jac/dkad047
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1175–1181, https://doi.org/10.1093/jac/dkad057
Calcium-binding motif-mediated binding of redundant calcium offers a chimeolysin enhanced bactericidal activity and extended host range under physiological conditions
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1182–1190, https://doi.org/10.1093/jac/dkad059
In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1191–1194, https://doi.org/10.1093/jac/dkad061
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1195–1200, https://doi.org/10.1093/jac/dkad062
Resistance to antibacterial antifolates in multidrug-resistant Staphylococcus aureus: prevalence estimates and genetic basis
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1201–1210, https://doi.org/10.1093/jac/dkad063
Efficacy of ceftazidime/avibactam in various combinations for the treatment of experimental osteomyelitis in rabbits caused by OXA-48-/ESBL-producing Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1211–1218, https://doi.org/10.1093/jac/dkad070
Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1219–1224, https://doi.org/10.1093/jac/dkad072
Contribution of amino acid substitutions in ParE to quinolone resistance in Haemophilus haemolyticus revealed through a horizontal transfer assay using Haemophilus influenzae
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1225–1230, https://doi.org/10.1093/jac/dkad074
Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1231–1240, https://doi.org/10.1093/jac/dkad079
CATALYST: challenging antibiotic allergy status
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1241–1244, https://doi.org/10.1093/jac/dkad081
Trends in antibiotic selection pressure generated in primary care and their association with sentinel antimicrobial resistance patterns in Europe
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1245–1252, https://doi.org/10.1093/jac/dkad082
Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1253–1258, https://doi.org/10.1093/jac/dkad083
Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1259–1264, https://doi.org/10.1093/jac/dkad086
Assessing the risk of adverse pregnancy outcomes and birth defects reporting in women exposed to ganciclovir or valganciclovir during pregnancy: a pharmacovigilance study
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1265–1269, https://doi.org/10.1093/jac/dkad087
Point prevalence audit surveys of respiratory tract infection consultations and antibiotic prescribing in primary care before and during the COVID-19 pandemic in Ireland
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1270–1277, https://doi.org/10.1093/jac/dkad088
No change in avilamycin (Surmax® Premix) minimum inhibitory concentration for Clostridium perfringens isolates recovered from poultry up to 7 years post-approval in Canada
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1278–1281, https://doi.org/10.1093/jac/dkad089
Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1282–1287, https://doi.org/10.1093/jac/dkad090
Characterization of a novel carbapenem-hydrolysing β-lactamase OXA-1041 in Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1288–1294, https://doi.org/10.1093/jac/dkad091
Multiple antibiotic resistance index (MARI) of human-isolated Salmonella species: a practical bacterial antibiotic surveillance tool
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1295–1299, https://doi.org/10.1093/jac/dkad092
Emergence of KPC-3- and OXA-181-producing ST13 and ST17 Klebsiella pneumoniae in Portugal: genomic insights on national and international dissemination
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1300–1308, https://doi.org/10.1093/jac/dkad093
Research Letters
Identification of a novel MDR plasmid co-harbouring the carbapenem resistance gene blaVIM-2 and tigecycline resistance gene cluster tmexCD1-toprJ1 in a Pseudomonas stutzeri isolate
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1309–1311, https://doi.org/10.1093/jac/dkad075
Emergence of a novel tigecycline resistance gene cluster tmexC3-tmexD5-toprJ2b in Oceanimonas sp. from chicken, China
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1311–1313, https://doi.org/10.1093/jac/dkad080
Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1314–1315, https://doi.org/10.1093/jac/dkad109
Letter to the Editor
Dalbavancin in Gram-positive periprosthetic joint infections–authors’ response
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Page 1316, https://doi.org/10.1093/jac/dkad069
